Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...

On December 8, 2025, NUPRC announced that the minimum financial requirement for an entity to participate in the 2025 ...

Texxon Holding Limited (Nasdaq: NPT) (the “Company” or “Texxon”), a leading provider of supply chain management services in the plastics and chemical industries in East China, today announced the ...

ASX-listed Green Technology Metals has received an extended letter of interest (LOI) from Export Development Canada (EDC) for potential financing support of up to C$100-million for the development of ...

First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026 Dosing ongoing in ...